VRTX Vertex Pharmaceuticals Earnings and EPS analysis

EPS in 2026 (TTM): $17.01

Last Report Period Date: Mar 31, 2026

As of June 2026, VRTX's current EPS stands at $17.01, according to the latest financial reports. For the year 2025, the company recorded an earnings per share (EPS) of $15.46, which marks an increase compared to its EPS of -$2.08 in 2024. VRTX reported an EPS of $4.06 for the quarterly report ending on Mar 31, 2026.

For 2025, Vertex Pharmaceuticals's EPS was $15.46, an increase of 843.3% from -$2.08 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $4.06, showing a 61.1% increase from the same quarter last year. For the twelve months ending March 2026, the EPS is $17.01. For the year 2024, the yearly earnings per share was -$2.08, marking a decrease of 114.8% from 2023.

During the last 12 months, Vertex Pharmaceuticals has seen an EPS growth of 61.1% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of 6% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of 8.2%.